The MassARRAY® technology has been used in genetic research settings for almost 20 years and has been featured in over 4,000 peer-reviewed publications globally. It brings a proven level of technological performance for molecular testing.
Featured Publications
Tumor Profiling ,
The impact of population-based EGFR testing in non-squamous metastatic Non-Small Cell Lung Cancer in Alberta
Lung Cancer 2022
Liquid Biopsy ,
A Micro-Costing Framework for Circulating Tumor DNA testing In Dutch Clinical Practice
The Journal of Molecular Diagnostics 2022
Infectious Disease ,
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
Microbiology Spectrum 2022
Hereditary Genetics ,
Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing
Clinica Chimica Acta 2022
Infectious Disease ,
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS
International Journal of Infectious Diseases 2022
PGx ,
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes